









市場行情
/
股票
/
nasdaq-anik
/

Anika Therapeutics Inc

ANIK

9.540USD

-0.030-0.31%

交易中（美東）報價延遲15分鐘

137.58M總市值

虧損本益比TTM



Anika Therapeutics Inc

9.540

-0.030-0.31%

概覽公司財務分析

概覽

公司

財務

分析

關於 Anika Therapeutics Inc 公司

Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.

Anika Therapeutics Inc簡介



公司代碼ANIK

公司名稱Anika Therapeutics Inc

上市日期May 16, 1985

CEOBlanchard (Cheryl Renee)

員工數量288

證券類型Ordinary Share

年結日May 16

公司地址32 Wiggins Ave

城市BEDFORD

上市交易所NASDAQ OMX - NASDAQ BASIC

國家United States of America

郵編01730-2315

電話17814579000

網址https://anika.com/

公司代碼ANIK

上市日期May 16, 1985

CEOBlanchard (Cheryl Renee)

Anika Therapeutics Inc公司高管



名稱

名稱/職務

職務

持股

持股變動

Dr. Glenn R. Larsen, Ph.D.

Independent Director

50.26K

+39.24%

Ms. Sheryl L. Conley

Independent Director

39.84K

+55.16%

Mr. William R. (Bill) Jellison

Independent Director

23.10K

+158.45%

Mr. Joseph H. (Joe) Capper

Independent Director

20.40K

+227.02%

Mr. Stephen D. (Steve) Griffin

Chief Financial Officer, Chief Operating Officer, Executive Vice President

9.07K

Mr. Matt Hall

Director, Corporate Development and Investor Relations

Mr. Ian McLeod

Chief Accounting Officer, Vice President, Treasurer

Mr. Gary P. Fischetti

Independent Director

Dr. Cheryl Renee Blanchard, Ph.D.

President, Chief Executive Officer, Director

Mr. David B. Colleran, J.D.

Executive Vice President, General Counsel, Secretary

名稱

名稱/職務

職務

持股

持股變動

Dr. Glenn R. Larsen, Ph.D.

Independent Director

50.26K

+39.24%

Ms. Sheryl L. Conley

Independent Director

39.84K

+55.16%

Mr. William R. (Bill) Jellison

Independent Director

23.10K

+158.45%

Mr. Joseph H. (Joe) Capper

Independent Director

20.40K

+227.02%

Mr. Stephen D. (Steve) Griffin

Chief Financial Officer, Chief Operating Officer, Executive Vice President

9.07K

Mr. Matt Hall

Director, Corporate Development and Investor Relations

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

業務USD

名稱

營收

佔比

OEM Channel

16.34M

57.90%

Commercial Channel

11.88M

42.10%

地區USD

名稱

營收

佔比

United States

17.92M

63.52%

Other

5.54M

19.64%

Europe

4.75M

16.84%

業務

地區

業務USD

名稱

營收

佔比

OEM Channel

16.34M

57.90%

Commercial Channel

11.88M

42.10%

股東統計

更新時間: 12月4日週四

持股股東

股東類型

持股股東

佔比

Trigran Investments, Inc.

11.24%

Caligan Partners, LP

9.95%

BlackRock Institutional Trust Company, N.A.

6.38%

The Vanguard Group, Inc.

5.41%

BlackRock Financial Management, Inc.

5.38%

其他

61.63%

持股股東

佔比

Trigran Investments, Inc.

11.24%

Caligan Partners, LP

9.95%

BlackRock Institutional Trust Company, N.A.

6.38%

The Vanguard Group, Inc.

5.41%

BlackRock Financial Management, Inc.

5.38%

其他

61.63%

股東類型

持股股東

佔比

Hedge Fund

29.85%

Investment Advisor/Hedge Fund

27.73%

Investment Advisor

25.43%

Individual Investor

4.88%

Research Firm

2.02%

Pension Fund

0.51%

Bank and Trust

0.12%

Venture Capital

0.09%

其他

9.38%

機構持股



更新時間: 12月8日週一

報告期間

機構數

持股數

持股佔比

持股變動

2025Q4

245

12.37M

97.19%

-666.00

2025Q3

267

12.37M

100.32%

-461.27K

2025Q2

295

12.88M

103.23%

-71.30K

2025Q1

297

12.95M

103.38%

-1.70M

2024Q4

298

12.83M

102.20%

-560.99K

2024Q3

297

13.48M

104.72%

-150.44K

2024Q2

301

13.64M

105.78%

+30.78K

2024Q1

301

13.61M

105.08%

-1.78M

2023Q4

304

13.45M

105.34%

+303.47K

2023Q3

297

13.16M

105.14%

-356.42K

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

Trigran Investments, Inc.

2.04M

14.12%

-5.34K

-0.26%

Jun 30, 2025

Caligan Partners, LP

1.44M

9.95%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

937.30K

6.5%

-20.13K

-2.10%

Jun 30, 2025

The Vanguard Group, Inc.

779.47K

5.41%

+2.07K

+0.27%

Jun 30, 2025

BlackRock Financial Management, Inc.

546.12K

3.79%

+24.11K

+4.62%

Jun 30, 2025

Acadian Asset Management LLC

575.64K

3.99%

+36.03K

+6.68%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

623.08K

4.32%

+9.11K

+1.48%

Jun 30, 2025

The Capital Management Corporation

408.85K

2.84%

+79.19K

+24.02%

Jun 30, 2025

Boothbay Fund Management, LLC

529.50K

3.67%

Jun 30, 2025

Renaissance Technologies LLC

527.22K

3.66%

-1.40K

-0.26%

Jun 30, 2025

持股ETF



更新時間: 12月6日週六

機構名稱

佔比

Invesco NASDAQ Future Gen 200 ETF

0.56%

Royce Quant Small-Cap Quality Value ETF

0.2%

SPDR SSGA US Small Cap Low Volatility Index ETF

0.1%

iShares Micro-Cap ETF

0.02%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

0.02%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

0.01%

Avantis US Small Cap Equity ETF

0.01%

Invesco RAFI US 1500 Small-Mid ETF

0.01%

WisdomTree US SmallCap Fund

0.01%

iShares Russell 2000 Value ETF

0.01%

Invesco NASDAQ Future Gen 200 ETF

佔比0.56%

Royce Quant Small-Cap Quality Value ETF

佔比0.2%

SPDR SSGA US Small Cap Low Volatility Index ETF

佔比0.1%

iShares Micro-Cap ETF

佔比0.02%

Goldman Sachs ActiveBeta US Small Cap Equity ETF

佔比0.02%

JPMorgan Diversified Return U.S. Small Cap Equity ETF

佔比0.01%

Avantis US Small Cap Equity ETF

佔比0.01%

Invesco RAFI US 1500 Small-Mid ETF

佔比0.01%

WisdomTree US SmallCap Fund

佔比0.01%

iShares Russell 2000 Value ETF

佔比0.01%

分紅派息



近5年累計派現 0.00 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

暫無數據

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Anika Therapeutics Inc的前五大股東是誰？



Anika Therapeutics Inc的前五大股東如下：
Trigran Investments, Inc.
持有股份：2.04M
佔總股份比例：14.12%。
Caligan Partners, LP
持有股份：1.44M
佔總股份比例：9.95%。
BlackRock Institutional Trust Company, N.A.
持有股份：937.30K
佔總股份比例：6.50%。
The Vanguard Group, Inc.
持有股份：779.47K
佔總股份比例：5.41%。
BlackRock Financial Management, Inc.
持有股份：546.12K
佔總股份比例：3.79%。